Custom Search Insider Trading Activity Insider Trading Activity

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Custom Search Insider Trading Activity

Updated Jun 17, 2024

Ticker
Company Name
Qty.
Price
Size ($)
Filing Date
Type
Δ Own
Own
Insider Names
Title
Trade Dates
Is Scheduled
Harrow, Inc.
0
—
—
—
0
Jun 14
Harpoon Therapeutics, Inc.
-5.00K
—
—
-100.00%
0
Mar 11
Harrow, Inc.
0
—
—
—
0
Jan 26
Harrow, Inc.
0
—
—
—
0
Harpoon Therapeutics, Inc.
5K
—
—
∞
5K
Nov 27
Harpoon Therapeutics, Inc.
0
—
—
—
0
Jun 22
Harpoon Therapeutics, Inc.
0
—
—
—
0
Sep 15
Harpoon Therapeutics, Inc.
0
—
—
—
0
Evolus, Inc.
-68.20K
$12.78
-$871,380.42
-32.51%
141.57K
May 17 - May 18
Evolus, Inc.
-10.19K
$9.73
-$99,121.28
-4.63%
209.78K
Mar 8
Scheduled
Evolus, Inc.
53.57K
—
—
+32.19%
219.97K
Jan 24
Evolus, Inc.
-14.29K
$11.18
-$159,774.30
-7.91%
166.4K
Aug 10
Scheduled
Evolus, Inc.
14.29K
$11.18
$159,774.30
+7.91%
194.98K
Aug 10
Scheduled
Evolus, Inc.
90K
—
—
+99.24%
180.69K
Jan 27
Evolus, Inc.
-2.70K
$7.46
-$20,134.54
-2.89%
90.69K
Jan 25
Scheduled
Evolus, Inc.
40K
—
—
+74.92%
93.39K
May 13
Evolus, Inc.
26K
—
—
+94.93%
53.39K
Jan 23
Evolus, Inc.
-2.61K
$13.53
-$35,352.11
-8.71%
27.39K
May 31
Evolus, Inc.
0
—
—
—
0
Jan 23
Evolus, Inc.
30K
—
—
∞
30K
May 29
Evolus, Inc.
0
—
—
—
0
Revance Therapeutics, Inc.
-2.87K
$30.25
-$86,924.42
-4.20%
65.5K
May 22
Scheduled
Revance Therapeutics, Inc.
-3.43K
$30.85
-$105,838.80
-4.78%
68.37K
+1
Mar 22
Scheduled
Revance Therapeutics, Inc.
-1.15K
$21.54
-$703,829.40
-1.58%
71.8K
+1
Mar 13 - Mar 15
Scheduled
Revance Therapeutics, Inc.
0
$20.35
-$466,000.00
—
72.95K
+1
Mar 7 - Mar 9
Scheduled
Revance Therapeutics, Inc.
-1.14K
$31.75
-$36,068.00
-1.53%
72.95K
+1
Feb 15
Revance Therapeutics, Inc.
8.13K
—
—
+12.32%
74.09K
+1
Feb 8
Revance Therapeutics, Inc.
-990.00
$33.50
-$33,165.00
-1.48%
65.97K
+1
Jan 28
Revance Therapeutics, Inc.
443
$22.99
$10,185.68
+0.67%
66.95K
+1
Dec 29
Revance Therapeutics, Inc.
17.51K
$8.70
$152,302.20
+35.72%
66.51K
+1
Dec 26
Revance Therapeutics, Inc.
0
$17.77
-$181,267.00
—
49.01K
+1
Nov 7
Scheduled
Revance Therapeutics, Inc.
-11.16K
$26.67
-$297,759.51
-18.55%
49.01K
+1
Oct 12
Scheduled
Revance Therapeutics, Inc.
604
$18.32
$11,063.77
+1.01%
60.17K
+1
Jun 30
Revance Therapeutics, Inc.
23K
$8.70
$200,100.00
+62.90%
59.57K
+1
May 26
Revance Therapeutics, Inc.
-1.79K
$20.20
-$36,212.15
-4.67%
36.57K
+1
May 22
Revance Therapeutics, Inc.
-1.27K
$19.20
-$24,365.82
-3.20%
38.36K
+1
Mar 16
Revance Therapeutics, Inc.
8.94K
$20.00
-$21,260.00
+29.12%
39.63K
+1
Jan 26 - Jan 28
Revance Therapeutics, Inc.
749
$11.56
$8,658.44
+2.50%
30.69K
+1
Jun 30
Revance Therapeutics, Inc.
-1.75K
$17.11
-$29,993.83
-5.53%
29.94K
+1
May 19
Revance Therapeutics, Inc.
10K
—
—
+46.09%
31.7K
+1
Feb 2

It looks like there's no data for these filter options. Maybe you'll be interested in these options instead.

Loading...

Want to view more results?

Unlock the hidden results with your Benzinga Account now. No purchase required.